Home › Rare-disease biotech companies surge in value - but some see a bubble
 

Keywords :   


Rare-disease biotech companies surge in value - but some see a bubble

2015-05-31 23:38:47| Biotech - Topix.net

Recent reports from Bloomberg have shown, the hunt for rare-disease medicines has created a buying frenzy among deal makers as takeover valuations jump to the highest in at least 20 years. Recent reports from Bloomberg have shown, the hunt for rare-disease medicines has created a buying frenzy among deal makers as takeover valuations jump to the highest in at least 20 years.

Tags: see some companies bubble

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
15.05Tom Hardy Is Jo Malone Londons New Ambassador for Cypress & Grapevine Cologne Intense
15.05Mooncat Introduces New Hue, Holds Bi-Annual Sale
15.05Eastern North Pacific Tropical Weather Outlook
More »